ASH 2011 Multiple Myeloma Update – Day Three Morning: New Therapies
Yesterday was the third day of the American Society of Hematology (ASH) 2011 Annual Meeting in San Diego, and it was packed full with multiple myeloma-related presentations. Presentations started early...
View ArticleMyeloma Research To Be Presented At The American Society of Clinical...
The 48th annual meeting of the American Society of Clinical Oncology (ASCO) will take place Friday, June 1, through Tuesday, June 5, in Chicago. More than 25,000 clinical specialists from all over the...
View ArticleVelcade-Treanda-Prednisone Combination May Be Effective In Newly Diagnosed...
Results of a small German study indicate that the combination regimen of Velcade, Treanda, and prednisone is effective and well tolerated in newly diagnosed multiple myeloma patients with kidney...
View ArticleASCO 2012 Multiple Myeloma Update – Day Three: New Myeloma Treatments
Today was the third day of the American Society of Clinical Oncology (ASCO) annual meeting, and the morning was filled with oral presentations about important myeloma-related studies. Most of the...
View ArticleRevlimid-Treanda-Prednisone Combo Is Active And Well Tolerated For...
Results from a recent German study suggest that a combination of Revlimid, Treanda and prednisone is active and well tolerated in patients with relapsed or refractory multiple myeloma. Findings from...
View ArticleRevlimid Maintenance Therapy Gets NCCN Vote Of Confidence
The National Comprehensive Cancer Network (NCCN) has updated its guidelines for the treatment of multiple myeloma, and the new guidelines will be interpreted by many as a vote of confidence for...
View ArticleASH 2012 Multiple Myeloma Update – Day Four: Oral Session
Tuesday was the final day of this year’s American Society of Hematology (ASH) meeting, which took place in Atlanta. The meeting concluded in the morning with a series of oral presentation sessions...
View ArticleBeacon NewsFlashes – March 11, 2013
Treanda May Enhance Response To Stem Cell Transplant In Myeloma Patients – Results from a Phase 1 clinical trial demonstrate the safety of adding Treanda (bendamustine) to melphalan (Alkeran) as...
View ArticleBeacon NewsFlashes – April 1, 2013
Entinostat And Treanda Enhance Each Other’s Efficacy Against Myeloma Cells – Results from a recent preclinical study show that Treanda (bendamustine) and the investigational drug entinostat (SNDX-275)...
View ArticleVelcade-Treanda-Prednisone Combo Demonstrates Efficacy And Improves Kidney...
Results from a recent retrospective analysis conducted in Germany indicate that the combination of Velcade plus Treanda and prednisone is effective for relapsed and refractory multiple myeloma...
View Article
